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Abstract
Background: Mendelian randomization (MR) studies use genetic variants mimicking the influence of a modifiable exposure
to assess and quantify a causal association with an outcome, with an aim to avoid problems with confounding and reverse
causality affecting other types of observational studies.
Aim: We evaluated genetic markers that index differences in 25-hydroxyvitamin D (25(OH)D) as instruments for MR studies
on vitamin D.
Methods and Findings: We used data from up-to 6,877 participants in the 1958 British birth cohort with information on
genetic markers and 25(OH)D. As potential instruments, we selected 20 single nucleotide polymorphisms (SNP) which are
located in the vitamin D metabolism pathway or affect skin pigmentation/tanning, including 4 SNPs from genome-wide
association (GWA) meta-analyses on 25(OH)D. We analyzed SNP associations with 25(OH)D and evaluated the use of allele
scores dividing genes to those affecting 25(OH)D synthesis (DHCR7, CYP2R1) and metabolism (GC, CYP24A1, CYP27B1). In
addition to the GWA SNPs, only two SNPs (CYP27B1, OCA2) showed evidence for association with 25(OH)D, with the OCA2
association abolished after lifestyle adjustment. Per allele differences varied between 20.02 and 20.08 nmol/L (P#0.02 for
all), with a 6.1 nmol/L and a 10.2 nmol/L difference in 25(OH)D between individuals with highest compared lowest number
of risk alleles in synthesis and metabolism allele scores, respectively. Individual SNPs but not allele scores showed
associations with lifestyle factors. An exception was geographical region which was associated with synthesis score.
Illustrative power calculations (80% power, 5% alpha) suggest that approximately 80,000 participants are required to
establish a causal effect of vitamin D on blood pressure using the synthesis allele score.
Conclusions: Combining SNPs into allele scores provides a more powerful instrument for MR analysis than a single SNP in
isolation. Population stratification and the potential for pleiotropic effects need to be considered in MR studies on vitamin
D.
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Introduction
There has been much interest in the potential effects of vitamin
D on a wide range of health outcomes, and vitamin D deficiency
has been suggested to predispose to common chronic diseases such
as diabetes, cancer and cardiovascular disease [1–6]. Effects on
bone health are undisputed and severe vitamin D deficiency leads
to rickets in children and osteomalacia in adults [7]. However, the
recent report by the Institute of Medicine on vitamin D, concluded
that ‘‘with the exception of measures related to bone health, the
potential indicators examined are currently not supported by
evidence that could be judged either convincing or adequate in
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terms of cause and effect, or informative regarding dose–response
relationships for determining nutrient requirements.’’ [8]. This
reflects the fact that much of the evidence has been obtained from
observational studies, with only a handful of randomized
controlled trials evaluating the effects of vitamin D supplementa-
tion.
Observational associations of 25-hydroxyvitamin D concentra-
tion (25(OH)D, a marker for nutritional vitamin D status) and
adverse health outcomes may provide evidence of a causal link,
but could also arise from limitations with this type of study. For
example, studies on vitamin D may be prone to confounding, as
status is associated with risk factors for chronic diseases such as
obesity [9]. Reverse causality may be a problem as given the
strong role of sunlight induced skin synthesis in vitamin D
production, lower concentrations of 25(OH)D could be a
consequence of less time spent outdoors and hence, caused by
an underlying disease rather than being the cause of it. Mendelian
randomization (MR) analysis refers to the use of genetic variants
that index the exposure of interest (in this case vitamin D intake/
status) to gain insight on whether the relationship between an
exposure and disease is causal [10,11]. If lower vitamin D status is
causally related to an adverse outcome (e.g. cardiovascular
disease), a genetic variant associated with lower 25(OH)D
concentration should be associated with a higher risk of
cardiovascular disease (in relation to its effect on 25(OH)D). The
genetic association, unlike the directly observed association of
vitamin D intake/status itself, will be less prone to confounding (as
the genotype is assigned at random) and free from reverse
causation since the genotype is not modifiable by disease [12].
Nevertheless, the MR approach has some limitations [12–14].
An assumption of MR analysis is that the effect of a genetic variant
on an outcome functions only via the intermediate exposure, such
as a lifestyle factor or biomarker. However, a genetic variant may
result in multiple biological alterations (pleiotropy). Hence, if these
alterations also independently affect relevant outcomes not via of
the intermediate phenotype, this may lead to associations through
a mechanism that does not involve the exposure of interest [10].
Genetic confounding may also result in violation of MR
assumptions if closely located genetic variants are inherited
together (i.e. in the presence of linkage disequilibrium) and affect
the outcome outside of the mechanism of the exposure, or if there
is evidence for population stratification [10].
In this study, we used information from the large nationwide
survey of 1958 British birth cohort to evaluate genetic markers for
the use as instruments in MR studies on vitamin D.
Methods
Ethics statement
Ethical approval for the biomedical survey was given by the
South-East Multi-Centre Research Ethics Committee. Written
informed consent for the use of information in medical studies was
obtained from the participants.
Participants
Detailed description of the study has been published previously
[15]. In brief, participants are from the 1958 British birth cohort
(1958BC), initially including all births in England, Scotland or
Wales during one week in March 1958 (n= 17,638) [15]. Between
September 2002 and June 2004, 11,971 participants still residing
in Britain were invited to participate in a biomedical survey. At the
time of data collection participants were aged 44–46 years old, and
9,377 (78%) completed at least one questionnaire and 7,591 (81%
of the respondents) had valid 25(OH)D measures. The 1958BC is
almost entirely a white European population (98%) [16], and since
we utilize genetic data for these analyses, 158 individuals of other
ethnic groups and one pregnant participant were excluded. Data
was further restricted by availability of genetic data with 4,572–
6,877 individuals included in the single nucleotide polymorphism
(SNP) analyses. Analyses using the vitamin D allele score were
done in participants with full data on 25(OH)D synthesis
(n = 5,623) and/or metabolism (n = 5,856) markers (for full
description, please see below).
Measurement of biochemical and clinical parameters
Serum 25(OH)D concentrations were measured using an
automated IDS OCTEIA enzyme-linked immunosorbent assay
(ELISA) (Dade-Behring BEP2000 analyzer), standardized accord-
ing to the mean from Vitamin D External Quality Assessment
Scheme (DEQAS) [17]. Serum IGF-1 concentration was mea-
sured using the Nichols Advantage IGF-1 chemiluminescence
immunoassay (referenced against World Health Organization 1st
International Reference Reagent 1988; IGF-1 87/518) and
glycosylated hemoglobin (HbA1C) with high-performance liquid
chromatography (as certified by the US National Glycohemoglo-
bin Standardization Program (NGSP) [18]). Triglycerides and
total and high-density lipoprotein (HDL) cholesterol were mea-
sured by standard autoanalyzer methodology and low-density
lipoprotein (LDL) cholesterol was calculated using the Friedewald
formula. Fibrinogen was determined by the Clauss method, D-
dimer by ELISA assay and C-reactive protein (CRP) was assayed
by nephelometry (Dade Behring). Von Willebrand factor (vWF)
antigen was measured by Decollates ELISA and tissue plasmin-
ogen activator (tPA) antigen by Biopool elisa. Total IgE was
assayed using the HYTEC automated enzyme immunoassay [19].
Weight, height and waist circumference were measured at 45
years of age. Blood pressure was determined as an average of three
repeated measures (Omron 705CP automated sphygmomanom-
eter). For forced expiratory volume 1 (FEV1) and forced vital
capacity (FVC), the highest technically satisfactory values (three
repeated measures) were used [20].
Social, dietary and lifestyle factors
Socioeconomic position was assessed using the Registrar
General’s occupational classification categorized as I and II
(managerial and professional), III (non-manual), III (manual),
and IV and V (manual unskilled) [21]. Individuals who were
institutionalized, retired, or long-term unemployed were classified
separately. Physical activity was determined as recreation Meta-
bolic Equivalent of Task (MET) hours, derived from reported
frequencies and usual durations for up to 37 activities [22].
Smoking was recorded as never/ex-smoker vs current smoker
based on smoking history recorded at ages 23, 33, and 42 years.
Frequency and amounts of alcohol consumption were reported at
45 years. Information on current geographical region of residence
was based on Government Office Regions, and categorized as
South (South East, South West, and Greater London), Middle
(East Anglia, Midlands, and Wales), North (North, North West,
and Yorkshire and the Humber), and Scotland. Geographical
region was dichotomized when used as an outcome (South/Middle
vs North/Scotland).
The following factors (measured at 45 years) were also
considered and dichotomized: time spent watching a television/
using a PC (coded as ,1 h vs $1 h), time spent outside (coded as
,1 h vs $1 h), protecting skin in the sun (often/sometimes vs
rarely/never), oily fish consumption ($3 days/week vs. 3 days/
week), use of vitamin D supplement, and season of blood drawn
(winter/spring vs. summer/autumn).
Mendelian Randomization Studies on Vitamin D
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Selection of candidate genes and SNPs
We selected 20 SNPs from 12 genes, which are involved in the
vitamin D pathway or affect skin pigmentation or the ability to tan
[23–26]. Four of the SNPs were identified as hits in the recently
published genome-wide association (GWA) meta-analysis for
vitamin D insufficiency (n,34,000, including the 1958 British
birth cohort) [23] (Figure 1). The GWA GC SNP rs2282679 was
in high linkage disequilibrium with the candidate GC SNP rs4588
(r2 = 0.98) and hence due to higher numbers with data available
(n = 6,551 vs. 5,224), we have chosen rs4588 as a proxy for the
SNP rs2282679 in the present study. Two of the SNPs were
identified as candidates based on the available evidence from the
literature pertaining to their potential roles in vitamin D metabolic
pathway (Figure 1). Fourteen SNPs were chosen based on the
GWA and candidate studies for skin colour/tanning. A complete
list of the selected genes/SNPs is shown in the Table S1.
Genotyping
The SNPs (rs4588, rs12785878, rs10741657, rs6013897,
rs10877012, rs17470271, rs7495174, rs4778241, rs4778138,
rs13289, rs1805005, rs2228479) were genotyped using the Taq-
man platform (Applied Biosystems, Warrington, UK) [27]. The
custom genotype SNPs had passed the inclusion criteria (Hardy-
Weinberg Equilibrium (HWE) P value .0.01 [28], MAF.0.01
and call rate .80%) (Table S1). The remaining SNPs were
genotyped on the platforms of Affymetrix 6.0 and Illumina 550 K
Infinium by the two sub-studies of WTCCC2 and TIDGC and
QC procedures were applied accordingly [29,30]. Imputation of
SNPs genotyped by the WTCCC2 and TIDGC was done using
the software Impute [31] (as outlined for the 1958BC in the
GWAS on 25(OH)D [23]). In the TIDGC sub-study, two SNPs
(rs16891982, rs1805007) were imputed, and in the WTCCC2,
three SNPs (rs16891982, rs11648785, rs464349) were imputed (a
call rate threshold of 0.9 was used for the imputed SNPs).
Statistical methods
Natural log transformation was used for 25(OH)D and the
biomarkers (except for lung function) to improve the approxima-
tion of the normal distribution. Distributions were assessed before
and after transformation using quantile-normal plots. Variation in
continuous outcomes was evaluated by linear regression and, in
dichotomous outcomes, by logistic regression with the p-values
from Wald tests.
The four SNPs in genes with confirmed associations with
25(OH)D (GC; rs4588, CYP2R1; rs10741657, DHCR7;
rs12785878, CYP24A1; rs6013897) [23] were considered as
possible instruments by default, and taken forward to subsequent
analyses. For the other genes, we tested their associations with
25(OH)D using linear regression, taking forward all SNPs with a
p-value below the Bonferroni corrected threshold of ,0.007
(#0.05/number of candidate genes) to control for multiple testing.
The number of candidate genes (rather than number of SNPs) was
used in Bonferroni correction to account for moderate linkage
disequilibrium between SNPs. To indicate the strength of the SNP
as instrument we included the F-statistic from a simple linear
regression model with 25(OH)D. The F-statistic in a simple linear
regression model is derived from the proportion of the variation
explained by the genetic variant in the phenotype given the sample
size [32]. As a rule of thumb an F-statistic less than 10 is taken to
indicate a weak instrument [33]. Formal MR analysis often uses
instrumental variable (IV) regression by two-stage least squares
estimator, however this may introduce a bias if sample size is small
and there is too much variability in the estimated association
between the SNP and intermediate phenotype [34]. The relative
bias of IV analysis compared to ordinary least squares (linear
regression) can be approximated as the inverse of the strength of
the instrument (1/F-statistic) [34]. Interactions between the SNPs
were tested by including the interaction terms in the linear
regression model on 25(OH)D adjusting for sex with p-values
corrected by the number of vitamin D SNPs to account for
multiple testing (0.05/5, P,0.01).
Relatively small proportion of participants had missing data on
confounders/covariates (15% with at least one missing value) after
restriction by the availability of genetic information. All main
analyses requiring confounder adjustments were run with com-
plete information. To investigate whether the results were sensitive
to missing information in covariates, multivariate imputation by
chained equations was used to impute missing values [35] and the
main analyses were re-run. The results were identical whether
based on models run on complete data or on data obtained by
multiple imputation. To assess whether the SNP associations with
Figure 1. Strategy for SNP selection using genome-wide association and candidate gene studies.
doi:10.1371/journal.pone.0037465.g001
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25(OH)D were confounded, we adjusted for lifestyle and social
factors in the linear regression model examining the associations of
the SNPs with 25(OH)D (namely time spent outside, sun cover,
oily fish consumption, vitamin D supplements, season, smoking,
alcohol consumption, PC/TV time, recreational metabolic
equivalent task (MET) hours, social class, body mass index
(BMI), abdominal obesity, geographical region, and sex). We also
analysed the direct associations between the SNPs and social,
dietary and lifestyle factors using logistic regression. Interactions
between the SNPs and lifestyle/social factors were evaluated by
including appropriate interaction terms in the model. In these
analyses a Bonferroni correction was used to correct for the
number of factors tested, with the p-value threshold determined as
0.05/14 (P,0.004).
To investigate whether the relationship between the SNPs and
25(OH)D was due to other health factors and differing genetic
pathways (‘‘genetic confounding’’), we adjusted for the available
biomarkers (von Willebrand factor, tPA, D-dimer, fibrinogen,
CRP, IgE, triglycerides, low density lipoproteins, high density
lipoproteins and total cholesterol, FEV, diastolic and systolic blood
pressures, IGF1 and HbA1c) in the linear regression model
examining the genetic marker association with 25(OH)D. We also
investigated the direct SNP- biomarker associations adjusted for
25(OH)D, with the assumption that if pleiotropy did exist these
associations should appear fairly strong, and not be affected by
25(OH)D adjustment. Interactions between 25(OH)D and SNPs
with biomarkers were also tested. Bonferroni corrected P-value for
these analyses was ,0.003 (0.05/15, where the denominator is the
number of biomarker tests for each SNP).
‘‘Synthesis score’’ was created using the two SNPs in genes
encoding proteins involved in 25(OH)D synthesis (DHCR7 and
CYP2R1), both of which had been identified through the GWA
meta-analyses on 25(OH)D [23]. Three SNPs in genes encoding
proteins involved in 25(OH)D metabolism (GC, CYP24A1 and
CYP27B1) were included in the ‘‘metabolism score’’, with analyses
repeated only including the GWA confirmed SNPs (‘‘metabo-
lismGWA score’’, GC and CYP24A1) (Figure 2). The allele score
was created by counting the number of vitamin D lowering alleles.
For alleles scores based on metabolizing genes (GC, CYP24A1 and
CYP27B1), there was only one subject with six lowering alleles, and
36 subjects with five lowering alleles, these groups were combined
with those who had four lowering alleles. Likewise for alleles in
genes involved in 25(OH)D synthesis (CYP2R1 and DHCR7) score,
only 97 subjects had four lowering alleles, so this group was
combined with those who had three lowering alleles. As described
above, we examined the associations of allelic score indicators with
potential confounders and disease-relevant biomarkers.
We used simulation to carry out illustrative power calculations
for the association between vitamin D and systolic blood pressure
using single SNPs, separate allele scores and allele scores together
as instruments (Appendix S1). We assumed effect sizes as
observed in the 1958BC, notably a 5% reduction in blood
pressure by each 10 nmol/l increase in 25(OH)D, and the
observed SNPs/scores effects on 25(OH)D. Data was simulated
1,000 times for a given sample size and two-staged least squares
regression was run. The parameter of interest was tested and
power was estimated from the proportion of times the test p-value
was less than the significant level a=0.05. Analyses were carried
out using STATA, version 11 [36].
Results
The 4 SNPs that had been chosen on the basis of the 25(OH)D
GWAS (in GC, CYP2R1, DHCR7, CYP24A1) [23] were associated
with 25(OH)D in the 1958BC (P#0.016). Of remaining 16 SNPS,
one SNP in OCA2 (rs7495174) had a significant association with
25(OH)D after Bonferroni correction (P=0.002) (Table 1). These
five SNPs were taken forward for further evaluation together with
one SNP (CYP27B1, rs10877012, P=0.008) (Figure 3) that fell
slightly below the significance threshold, but had previous
evidence for replication [37]. There was no evidence for SNP-
SNP interactions between any of the six SNPs (P for all
comparisons $0.08, data not presented).
We next examined whether the associations with 25(OH)D
observed for these six SNPs, were sensitive to adjustment for
geographical region, dietary and lifestyle factors or available
biomarkers (Figure 4). The missing data for the lifestyle and
dietary factors, and biomarkers ranged from 0.2% (BMI) to 7.7%
(time spent outside). Most associations between the SNPs and
25(OH)D concentrations were not affected by these adjustments,
however, an exception was OCA2, as its association was no longer
present after adjustment for sex, season, geographical region, time
spent outside, sun cover, oily fish consumption, vitamin D
supplements, smoking, alcohol consumption, PC/TV time,
recreational MET hours, social class at 42 yrs, and BMI (beta
20.06, P=0.007 for unadjusted vs. 20.02, P=0.27 adjusted,
Figure 4). Due to the lack of independent association with
25(OH)D, OCA2 was considered as unsuitable for the use as a
Figure 2. Genetic variation in the vitamin D synthesis and
metabolic pathway. Skin exposure to ultraviolet B (UVB) radiation
initiates the conversion of 7-dehydrocholesterol to previtamin D3. 7-
dehydrocholesterol reductase (DHCR7) encodes the enzyme 7-dehy-
drocholesterol reductase, which converts 7-dehydrocholesterol to
cholesterol, thereby removing the substrate from the synthetic pathway
of vitamin D3. The previtamin D3 in turn gets converted to vitamin D3
in a heat-dependent process. Vitamin D (represents D2 or D3) is
transported to the liver, where it is converted by vitamin D-25-
hydroxylase (CYP2R1) to 25-hydroxyvitamin D [25(OH)D]. This is the
major circulating form of vitamin D that is used by clinicians to
determine vitamin D status. This form of vitamin D is biologically
inactive; it is bound to the vitamin D-binding protein (GC), transported
to the kidneys and converted by 25-hydroxyvitamin D-1a- hydroxylase
(1-OHase) (CYP27B1) to the biologically active form 1,25-dihydroxyvi-
tamin D3 (Calcitriol). Calcitriol increases the expression of 25-
hydroxyvitamin D-24- hydroxylase (24-OHase) (CYP24A1) to catabolise
25(OH)D to the water-soluble, biologically inactive calcitroic acid, which
is excreted in the bile. DHCR7 and CYP2R1 function upstream of the
production of 25(OH)D and hence, termed as 25(OH)D synthesis
indicators, while GC, CYP27B1 and CYP24A1 function downstream of the
25(OH)D production and hence, termed as 25(OH)D metabolism
indicators.
doi:10.1371/journal.pone.0037465.g002
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proxy of 25(OH)D concentrations and removed from subsequent
analyses. For the remaining five SNPs, we found no significant
interactions by dietary and lifestyle factors on their influence on
25(OH)D (P.0.08 for all comparisons, data not presented). We
also observed no evidence for pleiotropic effects for these SNPs, as
no strong associations were observed with any of the available
biomarkers with adjustment for 25(OH)D concentrations (Table
S2). Furthermore, 25(OH)D did not modify the associations
observed between the SNPs and the biomarkers (P interaction for
all comparisons $0.07).
The combined 25(OH)D synthesis score (including SNPs in
DHCR7 and CYP2R1), explained 0.56% of the variation of
25(OH)D concentrations and there was a 6.1 nmol/l difference in
25(OH)D between top and bottom groups in the allelic score
(Table 2). The allele score based on 25(OH)D metabolism GWAS
SNPs (GC and CYP24A1) explained 1.04% of the variation of
25(OH)D concentrations and there was a 7.9 nmol/l difference in
25(OH)D between top and bottom groups in the allelic score,
while the metabolism score also including CYP27B1 explained
1.12% of the variation of 25(OH)D concentrations, with a
10.2 nmol/l difference between top and bottom quartile catego-
ries. As seen in Figure 4, associations between the allele scores
and 25(OH)D were unaffected by adjustment for lifestyle and
dietary factors or biomarkers. There were some associations
between individual SNPs and dietary and lifestyle factors, notably
rs10741657 from CYP2R1 which was associated with social class
(P=0.003), and GC SNP rs4588 which was associated with oily
fish consumption (P=0.002), while allele scores were not
associated with any of the lifestyle factors (Figure 5). However,
there was an association between 25(OH)D synthesis allele score
and geographical region even after applying Bonferroni correction
(for the number of dietary and lifestyle factors tested), which
reflected the strong association between DHCR7 SNP rs12785878
with geographical region (P=3.061025). As with the single
variants, we observed no evidence for pleiotropic effects as the
allele scores were not associated with the biomarkers after
adjustment for 25(OH)D (Table S2).
Illustrative power calculations for a MR study on blood pressure
using single SNPs, allele scores (synthesis, metabolism, metabo-
lismGWA), and allele scores combined as instruments for vitamin D
status are presented in Figure 6A & 6B. Allele scores had greater
power to detect an effect than the individual SNPs used in the
scores. For example, to achieve 80% power using the synthesis
allele score as instrument would require a sample size of 76,000
individuals, whilst using CYP2R1 alone would require 155,000
individuals.
Discussion
Insufficient intake of vitamin D has been proposed to affect up
to 50% of the UK population [38,39]. This is a potentially a very
important public health issue because vitamin D (intake and/or
deficiency) has been linked to several common diseases including
cancer, diabetes, and cardiovascular diseases [40]. However, there
Table 1. Association of SNP with ln 25-hydroxyvitamin D adjusted for sex.
Gene SNP n MAF
Beta for minor
allele SE P value
% of variance
explained F-statistic
Relative bias{,
%
GWA on 25(OH)D
GC rs4588 6027 0.30 20.08 0.009 1.48610217 1.18 73.4 1.4
DHCR7/NADSYN1 rs12785878 6504 0.22 20.05 0.009 1.261026 0.35 22.4 4.4
CYP2R1 rs10741657 5968 0.40 0.03 0.009 0.0003 0.21 13.3 8.1
CYP24A1 rs6013897 6534 0.20 20.03 0.010 0.016 0.07 5.4 21.1
Vitamin D pathway genes
CYP27B1 rs10877012 6877 0.33 20.02 0.008 0.008 0.09 7.2 16.8
CYP27A1 rs17470271 5831 0.44 0.005 0.009 0.55 - 0.4 -
GWA on skin colour/tanning
OCA2 rs7495174 5013 0.06 20.06 0.02 0.002 0.16 8.5 12.2
OCA2 rs4778241 4961 0.17 20.01 0.01 0.39 - 0.6 -
OCA2 rs4778138 5036 0.12 20.02 0.01 0.13 0.03 1.9 75.8
OCA2 rs12913832 4989 0.22 0.003 0.01 0.76 - 0.1 -
SLC45A2 rs13289 5039 0.38 20.02 0.009 0.013 0.10 6.5 19.3
SLC45A2 rs16891982 4843 0.02 20.03 0.04 0.48 - 0.5 -
MC1R rs11648785 4816 0.30 20.02 0.01 0.037 0.07 4.0 30.0
MC1R rs1805005 5091 0.12 0.02 0.01 0.14 0.02 2.0 81.6
MC1R rs464349 4966 0.46 20.01 0.01 0.25 0.01 1.5 -
MC1R rs2228479 5084 0.10 0.007 0.02 0.65 - 0.1 -
MC1R rs1805007 4572 0.10 20.003 0.02 0.87 - 0.0 -
IRF4 rs12203592 5184 0.22 20.01 0.01 0.20 0.01 1.6 -
IRF4 rs12210050 4988 0.20 20.01 0.01 0.58 - 0.3 -
TYR rs1393350 4992 0.29 0.01 0.01 0.48 - 0.5 -
MAF, minor allele frequency.
{Relative bias has not been estimated where the SNP has an F-statistic less than 1.9.
doi:10.1371/journal.pone.0037465.t001
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is an urgent need to improve the evidence base for causal relations
of vitamin D, as much of the evidence still relies on observational
studies where it is difficult to disentangle causation from
association. Randomized controlled trials are clearly the gold
standard for demonstrating causality, however, they are expensive
and time consuming. In this paper, we describe methodological
work related to a complementary approach for causal analysis;
notably, the rationale for identification and process to evaluate
25(OH)D associated SNPs as tools for future MR analysis of
vitamin D.
We identified five SNPs either affecting vitamin D synthesis or
metabolism as plausible instruments for MR analyses. We
observed some residual co-variation by lifestyle/dietary factors in
relation to selected instruments, for example the GC SNP was
associated with oily fish consumption. The GC SNP was also
marginally stronger in terms of F-statistic and variation of
25(OH)D concentrations explained than the combined un-
weighted allelic scores. Our analyses suggested that use of
combined allelic scores reduced confounding since the scores
were not associated with lifestyle/dietary factors. The associations
between selected SNPs and geographical region, and to some
extent with lifestyle/dietary factors, may also indicate a potential
issue with regional variation/ancestry. Hence, it is important to
consider population stratification in the context of MR studies on
vitamin D, and to correct for geographical region/population
stratification in related analyses. As genome-wide data becomes
more readily available, one approach might be to correct for
population stratification using principal components [41]. How-
ever, further work is required to demonstrate the extent to which
genes expressed in the vitamin D pathway are under genetic
selection related to geographical region.
The five genes used in the allelic scores have an important role
in the vitamin D metabolic pathway. DHCR7 and CYP2R1
function upstream of the 25(OH)D production (synthesis), while
GC, CYP24A1 and CYP27B1 function downstream of the 25(OH)D
production (metabolism) (Figure 2). CYP2R1 encodes the enzyme
that catalyzes the 25-hydroxylation step in the liver leading to the
synthesis of 25(OH)D [42], and as such, it is conceptually the best
instrument for MR studies on vitamin D. The SNP included in
these analyses is not functional, but it was chosen as it showed the
strongest association with 25(OH)D in the published GWAs meta-
analyses [23]. In the same study, DHCR7 was identified as a novel
locus for association with vitamin D status [23]. DHCR7 encodes
the enzyme 7-dehydrocholesterol reductase, which converts 7-
dehydrocholesterol (7-DHC) to cholesterol, removing the com-
pound from the pathway of vitamin D and onto becoming
25(OH)D. In our study, DHCR7 was not associated with
cholesterol (or other lipid makers) and there was no evidence for
effect modification by it on the association of 25(OH)D with
cholesterol biomarkers. Also the large GWA meta-analyses on
lipid traits failed to identify DHCR7 as a genetic influence on
cholesterol [43], suggesting it has a primary role for vitamin D
rather than cholesterol metabolism. Nevertheless, given the
possibility for pleiotropic associations, MR studies using DHCR7
to index 25(OH)D should be interpreted with caution if the
suggested association is not also seen for CYP2R1.
The strongest of the metabolism markers was vitamin D binding
protein (DBP), also known as group specific component (Gc),
which is involved in the transport of vitamin D and its metabolites
[44]. The enzyme encoded by the CYP24A1 gene plays a crucial
role in calcium homeostasis and the vitamin D endocrine system,
acting at the first stage of 25(OH)D and 1,25(OH)2D catabolism
[45]. CYP27B1 gene is a well-known candidate for vitamin D
pathway [45], as it encodes 1a-hydroxylase, the enzyme that
converts 25(OH)D into 1a-25(OH)2D (the active hormonal form).
Although our findings showed an association of the CYP27B1 SNP
(rs10877012) with 25(OH)D levels just outside the Bonferroni
corrected P,0.008, we also evaluated rs10877012 as a component
Figure 3. The selection of vitamin D SNPs for the use as instruments in Mendelian Randomization (MR) analysis.
doi:10.1371/journal.pone.0037465.g003
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of the allele score analysis based on the previous evidence for
replication [37]. Conversely, a candidate gene (OCA2) based on
the association with skin coloration was included in our initial
investigations. However, associations between OCA2 and
25(OH)D have not consistently been observed [27]. In our study
evidence for an association between the OCA2 genotype and
25(OH)D concentrations was abolished by adjustment for lifestyle
and social indicators, suggesting that this marker (despite
biological plausibility) is not suitable for the use as an instrument
in MR studies on vitamin D.
The position of the target gene in the metabolic vitamin D
pathway affects the quantification of the expected direction of the
SNP-25(OH)D association, which led us to divide the SNPs into
those affecting synthesis and metabolism when creating combined
allele score indicators. The ability to estimate the magnitude of a
possible causal effect for an environmental exposure that can be
improved is a key strength with the MR approach [11].
Conceptually, the quantification of the 25(OH)D association for
the synthesis markers appears quite straightforward as DHCR7 and
CYP2R1 contribute to the production of 25(OH)D. Associations
are likely to be more complex for the metabolism markers which
are involved in the clearance or transport of 25(OH)D (and other
vitamin D metabolites). The magnitude of the association between
metabolism SNPs and 25(OH)D may depend upon current
vitamin D status and requirement, and is likely to be under the
influence of (unmeasured, potentially unknown) metabolic feed-
back loops. For example, there is evidence to indicate that GC, the
key 25(OH)D carrier protein, is an important determinant of the
bioavailability of vitamin D metabolites to key target cells such as
*Figure 4. Association between the SNPs, synthesis, metabolism
and metabolismGWA allele scores and ln 25(OH)D with and
without adjustment for biomarkers, dietary and lifestyle
indicators. The bars are the 95% CI. Biomarkers: coagulation markers-
von Willebrand factor, tPA and D-dimer; Inflammatory markers-
fibrinogen and CRP; Lipid marker- Triglycerides, low density lipopro-
teins, high density lipoproteins and total cholesterol; Lung function
marker- FEV; Cardiovascular disease related factors- diastolic and
systolic blood pressures, IgE, IGF1 and HbA1c). Dietary and lifestyle
markers: time spent outside, sun cover, oily fish consumption, vitamin D
supplements, season, smoking, alcohol consumption, PC/TV time,
recreational MET hours, social class, body mass index, abdominal
obesity and geographical region.
doi:10.1371/journal.pone.0037465.g004
Table 2. Association of Allele Scores with ln 25-hydroxyvitamin D concentrations adjusted for sex.
N
Geometric Mean
(95% CI) Beta SE P value
% of variance
explained F-statistic
Relative
Bias, %
Synthesis score*
0 587 56.2 (54.0, 58.5) Reference Reference - - -
1 2025 55.1 (54.0, 56.2) 20.02 0.02 - - -
2 2276 53.0 (52.1, 54.0) 20.06 0.02 - - -
3,4 968 50.2 (48.8, 51.6) 20.11 0.02 - - -
Synthesis score, per allele 5856 - 20.04 0.007 6.161029 0.56 33.4 3.1
MetabolismGWA score{
0 1902 56.7 (55.5, 57.9) Reference Reference - -
1 2489 53.2 (52.3, 54.2) 20.06 0.01 - -
2 1305 50.3 (49.1, 51.5) 20.12 0.02 - -
3, 4 240 48.8 (46.0, 51.7) 20.15 0.03 - -
MetabolismGWA score,
per allele
5936 - 20.06 0.007 1.8610215 1.04 63.1 1.6
Metabolism score{
0 818 57.8 (56.0, 59.6) Reference Reference - -
1 1836 55.6 (54.4, 56.8) 20.04 0.02 - -
2 1767 52.6 (51.5, 53.7) 20.09 0.02 - -
3 925 51.0 (49.5, 52.5) 20.13 0.02 - -
4, 5, 6 277 47.6 (45.2, 50.2) 20.19 0.03 - -
Metabolism score,
per allele
5623 - 20.05 0.006 8.8610216 1.12 64.6 1.6
*Synthesis SNPs include DHCR7 and CYP2R1.
{MetabolismGWA SNPs include GC and CYP24A1.
{Metabolism SNPs include GC, CYP24A1 and CYP27B1.
doi:10.1371/journal.pone.0037465.t002
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monocytes [46], which will influence the use of related genetic
variants as instruments in MR analyses. Separating the SNPs by
function into the two allele scores gives flexibility to the subsequent
MR models, providing the ability to use them singularly as one
instrument or together as two instruments, whilst still accounting
for the complex associations with 25(OH)D.
An important strength with MR approach is that the
limitations for this method are by and large independent of
those typical for other types of observational studies. However, as
we have shown in this study, there remains a possibility of
residual confounding when using single SNPs as genetic proxy
markers. The single most important potential confounder was
geographical region, which also had a borderline association with
the allele score based on 25(OH)D synthesis SNPs. These
analyses highlight the importance of considering population
structure/regional variations in MR studies for vitamin D, which
given the strong influence of sunlight induced synthesis on serum
concentrations, may be particularly vulnerable to this source of
confounding.
MR relies on the assumption that genetic variants used as
instruments are uncorrelated with other variants that are
associated with the outcome outside of the exposure pathway
[12]. This assumption may be violated due to the presence of
linkage disequilibrium, where variants which are located close to
each other are inherited together. It is also possible that the
synthesis or metabolism SNPs could have led to biological
adaptations during the development (i.e. canalisation) [14]. It is
Figure 5. Associations of the five SNPs and allele scores with
geographical region, social, dietary and lifestyle factors. The
bars are the 99.6% CI. The effects of the allele scores and the individual
SNPs for each lifestyle factor can be identified based on the intensity of
the coloured boxes.
doi:10.1371/journal.pone.0037465.g005
Figure 6. Power and sample size to detect the 5% decrease in
blood pressure by 10 nmol/l increase in 25(OH)D observed in
the 1958 British birth cohort using genetic proxy indicators
(significance level a=0.05). The curves in (A) from the bottom to
the top of the graph are in the order of min effect size with CYP27B1
(short dash), CYP24A1 (long dash), DHCR7 (dash dot), CYP2R1 (dash), GC
(dot). The curves in (B) from the bottom to the top of the graph are in
the order of min effect size with Synthesis score (dash dot),
MetabolismGWA score (long dash) Metabolism score (dash), both scores
(dot). The horizontal black line and attached vertical dashed lines
indicate the sample size required for a study with 80% power using the
genetic proxy.
doi:10.1371/journal.pone.0037465.g006
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also possible that SNPs used as instruments could have
pleiotropic effects where they influence other metabolic pathways
independently of the influence on 25(OH)D concentrations. In
this study, we found no evidence for strong associations between
the SNPs of interest with a range of biomarkers, suggesting
specificity for their association with 25(OH)D. An important
methodological limitation for MR analyses, including those done
in the context of vitamin D, relates to the requirement of very
large sample sizes. In the illustrative power calculations included
in this paper, we showed how even by a combination of two SNPs
into an allele score we were able to half the sample size required.
In the MR analysis as modelled by IV regression using a two-
stage-least-squares estimator, the association can be biased when
both the variance explained by the instruments (in the
intermediate phenotype) and the sample size are small [33,34].
As indicated by the large F-statistics for all allele scores, none of
the composite instruments were deemed to be ‘‘weak’’ in our
study [33]. However, given the small amount of variation in
25(OH)D explained by these genetic variants, it is clear that the
application of MR analyses in the context of vitamin D is
resource intensive and as shown here, ,80,000 participants
would be required to detect expected influences on blood
pressure using the synthesis SNPs. If both allele scores are
combined, the sample size requirement is reduced to ,40,000
individuals. However, as noted above, quantification of the
association for the metabolism SNPs is difficult, and related
power calculations will not be correct if there are variations in
25(OH)D bioavailability by GC genotypes as has been suggested
[46].
There is great promise in the use of genetic variants as
instruments for modifiable exposures, given their ability to avoid
some of the limitations of observational epidemiology in making
causal inferences. At a public health level the benefits with the
approach are evident, as MR studies can be used to imply
reductions in disease risk that can be achieved by improving
vitamin D status (which in turn, can be done for example by the
use of vitamin D supplementation). However, in this paper we
demonstrate the complexities of using MR in the context of
vitamin D research, most notably the requirement of very large
samples, possibility for pleiotropic effects, and the potential of
confounding by population stratification. Informative MR studies
on vitamin D are likely to be feasible in the context of large
international consortia, with the issues on population structure
duly considered at the analysis stage. However, within that type of
context, MR is highly likely to serve as a useful first-stage approach
to testing causality between vitamin D and various health
outcomes.
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